Silverfin false false 30/11/2025 30/11/2025 01/12/2024 The principal activity of the Company during the financial year was specialist medical activities Deborah Jacqueline Duce 19/11/2018 Dr Michael Giles Simpson Dunnill 19/11/2018 11683193 2025-11-30 11683193 bus:Director1 2025-11-30 11683193 bus:Director2 2025-11-30 11683193 2024-11-30 11683193 core:CurrentFinancialInstruments 2025-11-30 11683193 core:CurrentFinancialInstruments 2024-11-30 11683193 2024-12-01 2025-11-30 11683193 bus:Micro-entities 2024-12-01 2025-11-30 11683193 bus:FilletedAccounts 2024-12-01 2025-11-30 11683193 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 11683193 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 11683193 bus:Director1 2024-12-01 2025-11-30 11683193 bus:Director2 2024-12-01 2025-11-30 11683193 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Company No: 11683193 (England and Wales)

DUNNILL DERMATOLOGY CONSULTING LTD

Unaudited Financial Statements
For the financial year ended 30 November 2025
Pages for filing with the registrar

DUNNILL DERMATOLOGY CONSULTING LTD

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 30 November 2025

Contents

DUNNILL DERMATOLOGY CONSULTING LTD

BALANCE SHEET

As at 30 November 2025
DUNNILL DERMATOLOGY CONSULTING LTD

BALANCE SHEET (continued)

For the financial year ended 30 November 2025
2025 2024
£ £
Fixed assets 238,623 134,526
Current assets 143,048 165,265
Creditors: amounts falling due within one year ( 25,205) ( 25,213)
Net current assets 117,843 140,052
Total assets less current liabilities 356,466 274,578
Accruals and deferred income ( 1,638) ( 1,559)
Net assets 354,828 273,019
Capital and reserves 354,828 273,019

For the financial year ending 30 November 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Dunnill Dermatology Consulting Ltd (registered number: 11683193) were approved and authorised for issue by the Board of Directors on 25 August 2026 and were signed on its behalf by:

Dr Michael Giles Simpson Dunnill
Director
DUNNILL DERMATOLOGY CONSULTING LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2025
DUNNILL DERMATOLOGY CONSULTING LTD

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 30 November 2025

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 11683193). The address of its registered office is 5th Floor 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 3 2